Teva Pharmaceutical Industries Statistics
NYSE: TEVAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
39.23+0.69 (+1.79%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Teva Pharmaceutical Industries by the numbers
Teva Pharmaceutical Industries has a market capitalization of $45.77 billion based on 1.17B shares outstanding. Its trailing P/E ratio is 91.2, above the 5-company peer median of 43.2, and its forward P/E is 12.5. The stock trades 3.4% below its 50-day average and 11.3% above its 200-day average.
Average daily trading volume is 6.31M shares, or about $247.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
TEVA valuation vs. peer median
| Metric | TEVA | Peer median | Difference |
|---|---|---|---|
| Market cap | $45.77B | $31.10B | +47% |
| P/E (TTM) | 91.2 | 43.2 | +111% |
| Forward P/E | 12.5 | 17.4 | -28% |
| Avg. volume | 6.31M | 3.70M | +71% |
Peer median across 8 companies: ONC, RPRX, ZTS, GMAB, INSM, ROIV, UTHR, VTRS.
Valuation
- Market cap
- $45.77B
- P/E (TTM)
- 91.23
- Forward P/E
- 12.53
- Price / sales (latest FY)
- 2.65
- EPS (TTM)
- $0.43
- Shares outstanding
- 1.17B
Price and trading
- Previous close
- 38.54
- Open
- 38.46
- Day range
- 38.30 – 39.91
- 52-week range
- 24.34 – 44.57
- 52-week change
- +62.04%
- Beta
- —
- Volume
- 6.81M
- Average volume
- 6.31M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 3, 2026
Additional statistics
- Market Cap
- 45.77B
- Pe
- 91.23
- Forward Pe
- 12.53
- Eps
- 0.43
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 44.57
- Week52 Low
- 24.34
- Avg Volume
- 6.31M
- Shares Outstanding
- 1.17B
- Ma50
- 40.62
- Ma200
- 35.25
- Earnings Date
- Nov 3, 2026
- Pct From52w High
- -11.98%
- Pct From52w Low
- 61.18%